Indicated for: diagnostic imaging
Route of administration: injectable
Substance: fludeoxyglucose (18F) (contrast agent)
ATC: V09IX04 (Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection)
Fludeoxyglucose (18F) is a radioactive compound used in medical imaging, especially in positron emission tomography (PET). It is a modified form of glucose labeled with fluorine-18, which allows visualization of the metabolic activity of various organs and tissues, being essential in diagnosing cancer, neurological diseases, or cardiac conditions.
It is administered by intravenous injection, and the patient is then scanned using a PET device. Fludeoxyglucose accumulates in areas with increased metabolic activity, allowing the doctor to identify possible tumors or other abnormalities.
Side effects are rare and usually minor, possibly including mild allergic reactions or discomfort at the injection site. Radiation exposure is low and considered safe for most patients, but the procedure is not recommended for pregnant women except in special cases.
Fludeoxyglucose (18F) is a valuable diagnostic tool that helps in the early detection and monitoring of diseases, but its use must be carried out under strict medical supervision.